Angiodysplasia risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Angiodysplasia}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Overview== ==...") |
No edit summary |
||
| (16 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angiodysplasia}} | {{Angiodysplasia}} | ||
{{CMG}}; {{AE}} {{NKT}} | |||
==Overview== | ==Overview== | ||
The most important [[risk factors]] for active bleeding from angiodysplasia include advanced age, cardiovascular [[comorbidities]], [[Von Willebrand disease|von Willebrand disease,]] [[End-stage renal disease|end-stage renal disease,]] and [[Antiplatelet drug|antiplatelet]] or [[Anticoagulants|anticoagulant]] use. | |||
==Risk Factors== | ==Risk Factors== | ||
The most important [[risk factors]] for active bleeding from angiodysplasia include:<ref name="pmid27596107">{{cite journal| author=Nishimura N, Mizuno M, Shimodate Y, Doi A, Mouri H, Matsueda K | display-authors=etal| title=Risk factors for active bleeding from colonic angiodysplasia confirmed by colonoscopic observation. | journal=Int J Colorectal Dis | year= 2016 | volume= 31 | issue= 12 | pages= 1869-1873 | pmid=27596107 | doi=10.1007/s00384-016-2651-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27596107 }} </ref><ref name="pmid30348493">{{cite journal| author=Tsai YY, Chen BC, Chou YC, Lin JC, Lin HH, Huang HH | display-authors=etal| title=Clinical characteristics and risk factors of active bleeding in colonic angiodysplasia among the Taiwanese. | journal=J Formos Med Assoc | year= 2019 | volume= 118 | issue= 5 | pages= 876-882 | pmid=30348493 | doi=10.1016/j.jfma.2018.10.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30348493 }} </ref> | |||
*Advanced age (>60 years) | |||
*Cardiovascular [[comorbidities]] like [[Hypertensive heart disease|hypertensive cardiovascular disease]], [[type 2 diabetes mellitus]], [[coronary artery disease]], [[valvular heart disease]], [[atrial fibrillation]] | |||
*[[von Willebrand disease]] | |||
*[[End-stage renal disease]] | |||
*[[Antiplatelet drug|Antiplatelet]] or [[Anticoagulants|anticoagulant]] use | |||
<br /> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Gastroenterology]] | ||
{{WS}} | |||
[[Category:Up to Date]] | |||
{{WH}} | |||
Latest revision as of 21:45, 25 April 2022
|
Angiodysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiodysplasia risk factors On the Web |
|
American Roentgen Ray Society Images of Angiodysplasia risk factors |
|
Risk calculators and risk factors for Angiodysplasia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]
Overview
The most important risk factors for active bleeding from angiodysplasia include advanced age, cardiovascular comorbidities, von Willebrand disease, end-stage renal disease, and antiplatelet or anticoagulant use.
Risk Factors
The most important risk factors for active bleeding from angiodysplasia include:[1][2]
- Advanced age (>60 years)
- Cardiovascular comorbidities like hypertensive cardiovascular disease, type 2 diabetes mellitus, coronary artery disease, valvular heart disease, atrial fibrillation
References
- ↑ Nishimura N, Mizuno M, Shimodate Y, Doi A, Mouri H, Matsueda K; et al. (2016). "Risk factors for active bleeding from colonic angiodysplasia confirmed by colonoscopic observation". Int J Colorectal Dis. 31 (12): 1869–1873. doi:10.1007/s00384-016-2651-1. PMID 27596107.
- ↑ Tsai YY, Chen BC, Chou YC, Lin JC, Lin HH, Huang HH; et al. (2019). "Clinical characteristics and risk factors of active bleeding in colonic angiodysplasia among the Taiwanese". J Formos Med Assoc. 118 (5): 876–882. doi:10.1016/j.jfma.2018.10.001. PMID 30348493.